Catalyst Pharmaceuticals Inc (CPRX)
15.12
+0.39
(+2.65%)
USD |
NASDAQ |
Apr 24, 16:00
15.12
0.00 (0.00%)
After-Hours: 07:48
Catalyst Pharmaceuticals Profit Margin (Quarterly): 31.51% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 31.51% |
September 30, 2023 | -29.96% |
June 30, 2023 | 37.92% |
March 31, 2023 | 34.64% |
December 31, 2022 | 41.92% |
September 30, 2022 | 39.74% |
June 30, 2022 | 40.70% |
March 31, 2022 | 30.73% |
December 31, 2021 | 24.30% |
September 30, 2021 | 28.73% |
June 30, 2021 | 33.50% |
March 31, 2021 | 25.37% |
December 31, 2020 | 36.88% |
September 30, 2020 | |
June 30, 2020 | 33.04% |
March 31, 2020 | 35.78% |
December 31, 2019 | 26.32% |
September 30, 2019 | 44.11% |
June 30, 2019 | 38.01% |
March 31, 2019 | -5.18% |
December 31, 2018 | -2.90K% |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-29.96%
Minimum
Sep 2023
44.11%
Maximum
Sep 2019
30.74%
Average
34.07%
Median
Profit Margin (Quarterly) Benchmarks
Pfizer Inc | -23.64% |
Sarepta Therapeutics Inc | 11.51% |
PTC Therapeutics Inc | -50.74% |
Corcept Therapeutics Inc | 23.16% |
Cytokinetics Inc | -8.19K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 20.45% |
Return on Assets | 16.92% |
Return on Invested Capital | 20.45% |
Gross Profit Margin (Quarterly) | 85.70% |
Operating Margin (Quarterly) | 37.71% |
Return on Net Operating Assets | 33.73% |